SNS Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.27M | Buy |
10,516
+950
| +10% | +$110K | 0.11% | 79 |
|
|
2025
Q4 | $1.02M | Buy |
9,566
+407
| +4% | +$38.2K | 0.09% | 83 |
|
|
2025
Q3 | $776K | Sell |
9,159
-79
| -0.9% | -$6.51K | 0.07% | 100 |
|
|
2025
Q2 | $739K | Sell |
9,238
-181
| -2% | -$14.4K | 0.07% | 100 |
|
|
2025
Q1 | $853K | Sell |
9,419
-134
| -1% | -$12.5K | 0.09% | 92 |
|
|
2024
Q4 | $958K | Buy |
9,553
+38
| +0.4% | +$3.92K | 0.1% | 84 |
|
|
2024
Q3 | $1.09M | Sell |
9,515
-376
| -4% | -$44.7K | 0.11% | 85 |
|
|
2024
Q2 | $1.23M | Sell |
9,891
-289
| -3% | -$37.2K | 0.13% | 77 |
|
|
2024
Q1 | $1.35M | Sell |
10,180
-249
| -2% | -$30.7K | 0.15% | 74 |
|
|
2023
Q4 | $1.15M | Sell |
10,429
-4,543
| -30% | -$472K | 0.14% | 74 |
|
|
2023
Q3 | $1.56M | Sell |
14,972
-9,663
| -39% | -$1.04M | 0.21% | 53 |
|
|
2023
Q2 | $2.86M | Sell |
24,635
-5,545
| -18% | -$630K | 0.37% | 38 |
|
|
2023
Q1 | $3.23M | Sell |
30,180
-6,843
| -18% | -$739K | 0.42% | 39 |
|
|
2022
Q4 | $4.13M | Sell |
37,023
-154
| -0.4% | -$15.7K | 0.56% | 34 |
|
|
2022
Q3 | $3.23M | Sell |
37,177
-147
| -0.4% | -$13.1K | 0.46% | 39 |
|
|
2022
Q2 | $3.43M | Sell |
37,324
-23
| -0.1% | -$2.04K | 0.45% | 39 |
|
|
2022
Q1 | $3.06M | Buy |
37,347
+66
| +0.2% | +$5.2K | 0.34% | 49 |
|
|
2021
Q4 | $2.86M | Buy |
37,281
+1,053
| +3% | +$83.9K | 0.31% | 50 |
|
|
2021
Q3 | $2.72M | Buy |
36,228
+1,153
| +3% | +$87.7K | 0.33% | 45 |
|
|
2021
Q2 | $2.73M | Buy |
35,075
+40
| +0.1% | +$2.98K | 0.35% | 45 |
|
|
2021
Q1 | $2.58M | Buy |
35,035
+290
| +0.8% | +$21.4K | 0.34% | 48 |
|
|
2020
Q4 | $2.71M | Buy |
34,745
+27,256
| +364% | +$2.08M | 0.39% | 43 |
|
|
2020
Q3 | $593K | Sell |
7,489
-6
| -0.1% | -$470 | 0.09% | 114 |
|
|
2020
Q2 | $553K | Buy |
7,495
+5
| +0.1% | +$376 | 0.1% | 112 |
|
|
2020
Q1 | $549K | Sell |
7,490
-778
| -9% | -$61.1K | 0.11% | 120 |
|
|
2019
Q4 | $718K | Sell |
8,268
-538
| -6% | -$44.2K | 0.13% | 107 |
|
|
2019
Q3 | $707K | Sell |
8,806
-994
| -10% | -$79.7K | 0.13% | 93 |
|
|
2019
Q2 | $784K | Buy |
9,800
+553
| +6% | +$42.3K | 0.15% | 89 |
|
|
2019
Q1 | $734K | Sell |
9,247
-190
| -2% | -$14.2K | 0.16% | 89 |
|
|
2018
Q4 | $688K | Buy |
9,437
+981
| +12% | +$69.3K | 0.17% | 93 |
|
|
2018
Q3 | $573K | Sell |
8,456
-21
| -0.2% | -$1.34K | 0.14% | 93 |
|
|
2018
Q2 | $491K | Buy |
8,477
+686
| +9% | +$38.7K | 0.13% | 92 |
|
|
2018
Q1 | $405K | Sell |
7,791
-1,022
| -12% | -$55.2K | 0.11% | 105 |
|
|
2017
Q4 | $474K | Sell |
8,813
-680
| -7% | -$37.7K | 0.11% | 107 |
|
|
2017
Q3 | $580K | Buy |
9,493
+285
| +3% | +$17.3K | 0.15% | 94 |
|
|
2017
Q2 | $563K | Sell |
9,208
-52
| -0.6% | -$3.17K | 0.15% | 98 |
|
|
2017
Q1 | $561K | Buy |
+9,260
| New | +$562K | 0.14% | 99 |
|
Other funds holding MRK
VCM
VPM
SNS Financial Group's MRK Position: Q1 2026 in Review
SNS Financial Group increased its Merck (MRK) stake by 9.9% in Q1 2026, buying an estimated $110K and bringing the position to 10,516 shares worth $1.27M. The position accounts for 0.11% of the portfolio, ranked #79.
SNS Financial Group first reported a position in MRK in Q1 2017 and has held it in 37 quarters since. The position peaked at $4.13M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- SNS Financial Group held 10,516 shares of Merck worth $1.27M as of Q1 2026.
- SNS Financial Group bought 950 Merck shares in Q1 2026, an estimated $110K.
- Merck made up 0.11% of SNS Financial Group's portfolio in Q1 2026, its #79 holding.
- SNS Financial Group first reported a position in Merck in Q1 2017 and has held it in 37 quarters since.
- SNS Financial Group's Merck position peaked at $4.13M in Q4 2022.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.